Autonomix Medical Q2 FY26 net loss narrows 18.18% to $2.7 million

Reuters2026/08/13 10:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Autonomix Medical posted a GAAP net loss of USD 2.7 million for the quarter ended June 30, 2026.
Total operating expenses fell 19% to USD 2.77 million, led by a 31% drop in general and administrative costs to USD 1.26 million.
Research and development spending edged down 5% to USD 1.52 million.
Cash totaled USD 3.5 million, with working capital of USD 3.1 million; cash runway is expected into but not beyond Q1 2027.
In July, Nasdaq bid-price compliance was regained; a warrant inducement brought about USD 2.6 million in gross proceeds.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-027429), on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Autonomix Medical Q2 FY26 net loss narrows 18.18% to $2.7 million

You may also like

Crypto prices